Horizon scanning is a strategic tool used by regulatory bodies to identify emerging technologies and guide decision-making. In its latest report on nanomedicines, the European Union Innovation Network presents key recommendations that illustrate the current dynamics between researchers and regulators and how strengthening this relationship could accelerate the translation of nanotechnology-based medicines into patient benefit.
- Yoana Nuevo
- Eva Hemmrich
- Tomáš Boráň
